Rhone-Poulenc reorganization to combine RPR and vaccines business: prelude to spin-off?.
Executive Summary
RHONE-POULENC PHARMACEUTICALS COMBINES RPR, PASTEUR-MERIEUX CONNAUGHT under the leadership of Group President Igor Landau, effective Jan. 1. Rhone-Poulenc SA is reorganizing its health and agro operations, the company said Nov. 18. Rhone-Poulenc Rorer will continue to be directed by Chairman Michel de Rosen and Pasteur Merieux Connaught will continue to be run by Chairman Jean-Jacques Bertrand. The vaccines business recently combined the Pasteur-Merieux and Connaught operations under one corporate rubric ("The Pink Sheet" Nov. 18, In Brief).